Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 210.30K | 287.90K | 978.30K | 512.30K | 67.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 396.60K | 523.90K | 1.21M | 762.70K | 280.10K |
| Operating Income | -396.60K | -523.90K | -1.21M | -762.70K | -280.10K |
| Income Before Tax | 7.00M | -386.90K | -701.60K | -1.38M | -579.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.00M | -386.90K | -701.60K | -1.38M | -579.50K |
| Earnings from Discontinued Operations | -144.30K | -- | -- | -- | -328.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.86M | -386.90K | -701.60K | -1.38M | -907.90K |
| EBIT | -396.60K | -523.90K | -1.21M | -762.70K | -280.10K |
| EBITDA | -379.10K | -475.90K | -1.15M | -684.60K | -181.00K |
| EPS Basic | 6.34 | -0.36 | -0.65 | -1.35 | -0.91 |
| Normalized Basic EPS | -0.20 | -0.22 | -0.41 | -0.84 | -0.36 |
| EPS Diluted | 6.34 | -0.36 | -0.65 | -1.35 | -0.91 |
| Normalized Diluted EPS | -0.20 | -0.22 | -0.41 | -0.84 | -0.36 |
| Average Basic Shares Outstanding | 1.08M | 1.08M | 1.08M | 1.02M | 1.00M |
| Average Diluted Shares Outstanding | 1.08M | 1.08M | 1.08M | 1.02M | 1.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |